MedPath

National Survey on Asthma

Completed
Conditions
Asthma
Registration Number
NCT00770250
Lead Sponsor
AstraZeneca
Brief Summary

To evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1704
Inclusion Criteria
  • A diagnosis of persistent asthma treated with an inhaled corticosteroid based maintenance treatment for more than 3 months
  • Given his/her consent to participate to the study and who is able to answer the questionnaire in french by him/her-self.
Exclusion Criteria
  • Patient with a cardiac disease (congestive heart failure, coronary artery disease)
  • Patient with a respiratory disease other than asthma (COPD, sleep apnea syndrome).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control.Once
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Research Site

🇫🇷

Zuydcoote, France

© Copyright 2025. All Rights Reserved by MedPath